Cancer Research Targets  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 160, January 1, 2007. doi: 10.1158/0008-5472.CAN-06-3326
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwanaga, Y.
Right arrow Articles by Jeang, K.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwanaga, Y.
Right arrow Articles by Jeang, K.-T.

Cell, Tumor, and Stem Cell Biology

Heterozygous Deletion of Mitotic Arrest–Deficient Protein 1 (MAD1) Increases the Incidence of Tumors in Mice

Yoichi Iwanaga1, Ya-Hui Chi1, Akiko Miyazato1, Sergey Sheleg1, Kerstin Haller1, Jean-Marie Peloponese, Jr.1, Yan Li1, Jerrold M. Ward2, Robert Benezra3 and Kuan-Teh Jeang1

1 Molecular Virology Section, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases and 2 Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland; and 3 Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York

Requests for reprints: Kuan-Teh Jeang, NIH, Building 4, Room 306, 9000 Rockville Pike, Bethesda, MD 20892-0460. Phone: 301-496-6680; Fax: 301-480-3686; E-mail: kj7e{at}nih.gov.

Mitotic arrest–deficient protein 1 (MAD1) is a component of the mitotic spindle assembly checkpoint. We have created a knockout mouse model to examine the physiologic consequence of reduced MAD1 function. Mad1+/– mice were successfully generated, but repeated paired mating of Mad1+/– with Mad1+/– mice failed to produce a single Mad1–/– animal, suggesting that the latter genotype is embryonic lethal. In aging studies conducted for >18 months, Mad1+/– mice compared with control wild-type (wt) littermates showed a 2-fold higher incidence of constitutive tumors. Moreover, 42% of Mad1+/– (P < 0.03), but 0% of wt, mice developed neoplasia after treatment with vincristine, a microtubule depolymerization agent. Mad1+/– mouse embryonic fibroblasts (MEF) were found to be more prone than wt cells to become aneuploid; Mad1+/–, but not wt, MEFs produced fibrosarcomas when explanted into nude mice. Our results indicate an essential MAD1 function in mouse development and correlate Mad1 haploinsufficiency with increased constitutive tumors. [Cancer Res 2007;67(1):160–6]




This article has been cited by other articles:


Home page
JCBHome page
M. Li, X. Fang, Z. Wei, J. P. York, and P. Zhang
Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice
J. Cell Biol., June 15, 2009; 185(6): 983 - 994.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. A.A. Weaver and D. W. Cleveland
The role of aneuploidy in promoting and suppressing tumors
J. Cell Biol., June 15, 2009; 185(6): 935 - 937.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Schliekelman, D. O. Cowley, R. O'Quinn, T. G. Oliver, L. Lu, E.D. Salmon, and T. Van Dyke
Impaired Bub1 Function In vivo Compromises Tension-Dependent Checkpoint Function Leading to Aneuploidy and Tumorigenesis
Cancer Res., January 1, 2009; 69(1): 45 - 54.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-H. Chi, K. Haller, M. D. Ward, O. J. Semmes, Y. Li, and K.-T. Jeang
Requirements for Protein Phosphorylation and the Kinase Activity of Polo-like Kinase 1 (Plk1) for the Kinetochore Function of Mitotic Arrest Deficiency Protein 1 (Mad1)
J. Biol. Chem., December 19, 2008; 283(51): 35834 - 35844.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. M.-F. Sze, Y.-P. Ching, D.-Y. Jin, and I. O.-L. Ng
Role of a Novel Splice Variant of Mitotic Arrest Deficient 1 (MAD1), MAD1{beta}, in Mitotic Checkpoint Control in Liver Cancer
Cancer Res., November 15, 2008; 68(22): 9194 - 9201.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. H. Lee, H. Sterling, A. Burlingame, and F. McCormick
Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle checkpoint
Genes & Dev., November 1, 2008; 22(21): 2926 - 2931.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. A. Rajasekaran, J. J. Christiansen, I. Schmid, E. Oshima, K. Sakamoto, J. Weinstein, N. P. Rao, and A. K. Rajasekaran
Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability
Mol. Cancer Ther., July 1, 2008; 7(7): 2142 - 2151.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
K. Jeganathan, L. Malureanu, D. J. Baker, S. C. Abraham, and J. M. van Deursen
Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis
J. Cell Biol., October 22, 2007; 179(2): 255 - 267.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.